Search Results - Hilda Ding
- Showing 1 - 2 results of 2
-
1
Pediatric Aggressive Mature B-Cell Lymphomas, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology by Kimberly Davies, Matthew J. Barth, Saro H. Armenian, Anthony N. Audino, Phillip Barnette, Branko Cuglievan, Hilda Ding, James B. Ford, Paul J. Galardy, Rebecca Gardner, Rabi Hanna, Robert J. Hayashi, Alexandra E. Kovach, Andrea Judit Machnitz, Kelly W. Maloney, Lianna J. Marks, Kristin Page, Anne F. Reilly, Joanna Weinstein, Ana C. Xavier, Nicole R. McMillian, Deborah A. Freedman-Cass
Published 2020Artigo -
2
Pediatric relapsed/refractory ALK+ anaplastic large cell lymphoma treatment and outcomes in the targeted drug era by Lianna J. Marks, Victor Ritter, Jennifer E. Agrusa, Kala Y. Kamdar, Julie Rivers, Rebecca Gardner, Matthew J. Ehrhardt, Kaitlin J. Devine, Charles Phillips, Anne F. Reilly, Keith J. August, Joanna Weinstein, Prakash Satwani, Christopher J. Forlenza, Christine M. Smith, Chelsee Greer, Zeinab Afify, Carol Lin, Jennifer A. Belsky, Hilda Ding, David J. Hoogstra, Keri Toner, Michael P. Link, Liora M. Schultz, Eric Lowe, Catherine Aftandilian
Published 2025Artigo
Search Tools:
Related Subjects
Astrobiology
Cancer
Internal medicine
Lymphoma
Medicine
Oncology
Physics
Refractory (planetary science)
ALK inhibitor
Aggressive lymphoma
Anaplastic large-cell lymphoma
Anaplastic lymphoma kinase
Brentuximab vedotin
CD30
Chemotherapy
Chemotherapy regimen
Crizotinib
Disease
Gastroenterology
Hematopoietic stem cell transplantation
Malignant pleural effusion
Pediatric oncology
Pleural effusion
Regimen
Retrospective cohort study
Rituximab
Targeted therapy
Transplantation